Physician profile
Brian C Scull
NPI 1780655639
$809.47
in general payments reported to CMS, 2019-2025
10 companies · $342 in 2025
The $342 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.58 · 2023: $136 · 2024: $311 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $235.28 | 2022-2025 | Apretude, Cabenuva |
| Glaxosmithkline, LLC. | $209.58 | 2023-2024 | Arexvy, Shingrix, Bexsero |
| Sanofi Pasteur INC. | $110.56 | 2024-2025 | |
| Abbott Laboratories | $68.30 | 2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $51.56 | 2024 | |
| Abbvie INC. | $40.30 | 2025 | |
| Novo Nordisk INC | $32.72 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Teleflex LLC | $24.57 | 2025 | Urolift |
| Takeda Pharmaceuticals U.S.A., INC. | $23.04 | 2024 | Vpriv |
| Medtronic, INC. | $13.56 | 2024 | Symplicity G3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Scull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.